Pope, Janet E. http://orcid.org/0000-0003-1479-5302
Denton, Christopher P. http://orcid.org/0000-0003-3975-8938
Johnson, Sindhu R. http://orcid.org/0000-0003-0591-2976
Fernandez-Codina, Andreu
Hudson, Marie
Nevskaya, Tatiana
Article History
Accepted: 6 January 2023
First Online: 27 February 2023
Competing interests
: J.E.P. declares that she has research grants from AbbVie, Bayer, BI, BMS, Frensenius Kabi, Lilly, Mallinckrodt Pharmaceuticals, Merck, Roche, Seattle Genetics; that she has consulted for AbbVie, Amgen, BI, BMS, Celltrion, EMERALD, Frensenius Kabi, Galapagos, Gilead, Janssen, Lilly, Mallinckrodt Pharmaceuticals, Medexus, Merck, Mitsubishi Tanabe Pharma, Novartis, Pfizer, Roche, Sandoz, Samsung, Sanofi, Sobi, Teva, Viatris; and that she has been a speaker or attended an advisory board for AbbVie, Amgen, BI, BMS, Frensenius Kabi, Galapagos, Gilead, Janssen, Lilly, Merck, Novartis, Pfizer, Sandoz, Sanofi, UCB. C.P.D. declares that he has received consultancy or speaker fees from GlaxoSmithKline, Roche, Boehringer Ingelheim, Sanofi-Aventis, Galapagos, Inventiva, Corbus, Acceleron, Horizon, Gesynta; and that he has received research grants to his institution from GlaxoSmithKline, ARXX Therapeutics, Servier and Horizon Therapeutics. S.R.J. declares that he has been a site investigator for clinical trials sponsored by Bayer, Boehringer Ingelheim, Corbus, GlaxoSmithKline; that he has served on advisory boards for Boehringer Ingelheim, Corbus and Ikaria; and that he has been supported by the Oscar and Eleonor Markovitz Scleroderma Research Fund and the Gurmej Kaur Dhanda Scleroderma Research Fund. A.F.-C. declares that he has received grant support from the Scleroderma Society of Ontario and honoraria from Actelion, Bayer, Boehringer-Ingelheim. M.H. declares that she has received research grants from Boehringer Ingelheim and Bristol Myers Squibb and that she has participated in advisory boards for Boehringer Ingelheim, Alexion and Mallinckrodt. T.N. declares no competing interests.
Free to read: This content has been made available to all.